UK Police to Evaluate Train Operators on Sexual Harassment Response No Financial Penalties Attached AI Chipmakers SK Hynix and Micron Join 1 Trillion Market Cap Club Amid Rally Sensex Dips 142 Points Nifty Holds Above 23900 as Mid and SmallCaps Shine GTS Securities Dumps 354 Million in XOVR Shares Slashing Stake to Near Zero HS2s Cost Ballooning to 1027bn and Delays to 2039 Raise Fresh Questions Over UK Infrastructure Spending Goldman Sachs CEO David Solomon AIDriven Mass Unemployment Concerns Overblown Sees Job Growth Potential Paramount Skydance Corporation PSKY Q1 2026 Earnings EPS Surges Past Expectations Stock Rises Quantum Biopharma Ltd QNTM Q4 2025 Earnings Net Loss Deepens as PreRevenue Stock Sheds 237 Kratos Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher REAX Q1 2026 Earnings NarrowerThanExpected Loss Fails to Move Shares IHG Q4 2025 Earnings EPS Misses Estimates Stock Edges Lower Barings BDC Inc BBDC Q1 2026 Earnings EPS Misses Estimates Amid Stable Market Conditions Gain Therapeutics GANX Surges 147 as Volume Picks Up Testing Resistance at 213 ASGN Incorporated ASGN Plunges 5169 Key Levels and What Lies Ahead Li Bang International LBGJ Posts Modest Gain Hovers Near Key Resistance at 098 Greenwich LifeSciences Inc GLSI Edges Higher as Shares Approach Key Resistance Akebia Therapeutics AKBA Holds Steady at 102 as Support and Resistance Levels Tighten Trump Reverses AI Safety Review Requirement in Executive Order Tech Industry Prevails LOB Q1 2026 Earnings Strong EPS Beat Despite Modest Stock Pullback Foxx Development Holdings FOXX Plunges 1574 Key Levels and Market Dynamics abrdn Global Infrastructure Income Fund ASGI Holds Steady Near Midpoint of Range DarioHealth Corp DRIO Surges Over 5 as Digital Health Stock Tests Key Resistance RZC Holds Steady at 2542 Amid Flat Trading Reinsurance Group of America Subordinated Debt Analysis Celanese Corporation CE Holds Near Support Amid Broader Market Pressure Sequans Communications SQNS Slides 55 as Selling Pressure Mounts Key Levels in Focus Pulse Biosciences PLSE Rises Modestly as Shares Test Key Resistance Coeptis Therapeutics COEP Holds Steady at 1640 Key Levels to Watch